Ezetimibe Desfluoro benzene Analog
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

190595-66-5Ezetimibe Desfluoro benzene Analog

● In Stock

Catalogue No.:VL203013
CAS No.:190595-66-5
Mol. Formula:C24H22FNO3
Mol. Weight:391.43 g/mol

Additional information on CAS 190595-66-5

Parent drug

Ezetimibe

IUPAC Name

(3R, 4S)-1-Phenyl-3-[(3S)-3-(4-fluorophenyl) -3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone

Pharmacopoeial Synonyms

N/A

Other Synonyms

(3’S,3R,4S)-Desfluoro Ezetimibe; Ezetimibe Desfluoro Impurity A

Smile

O=C1N(C2=CC=CC=C2)[C@H](C3=CC=C(O)C=C3)[C@H]1CC[C@@H](C4=CC=C(F)C=C4)O

InChI

InChI=1S/C24H22FNO3/c25-18-10-6-16(7-11-18)22(28)15-14-21-23(17-8-12-20(27)13-9-17)26(24(21)29)19-4-2-1-3-5-19/h1-13,21-23,27-28H,14-15H2/t21-,22+,23-/m1/s1

Description

Ezetimibe Desfluoro benzene Analog is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Ezetimibe . It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications. Ezetimibe Desfluoro benzene Analog (CAS No. 190595-66-5) is associate impurity of Ezetimibe. Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. Ezetimibe is used as adjunctive therapy to a healthy diet to lower cholesterol levels in primary hyperlipidemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia, and homozygous sites.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url